These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 7406638

  • 1. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
    Hussain MA, Green N, Flynn DM, Hussein S, Hoffbrand AV.
    Lancet; 1976 Dec 11; 2(7998):1278-80. PubMed ID: 63749
    [Abstract] [Full Text] [Related]

  • 3. Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.
    Hussain MA, Green N, Flynn DM, Hoffbrand AV.
    Lancet; 1977 May 07; 1(8019):977-9. PubMed ID: 67469
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reassessment of the use of desferrioxamine B in iron overload.
    Propper RD, Shurin SB, Nathan DG.
    N Engl J Med; 1976 Jun 24; 294(26):1421-3. PubMed ID: 1272274
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC.
    Trans Assoc Am Physicians; 1977 Jun 24; 90():335-41. PubMed ID: 611665
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
    Hoffbrand AV, Gorman A, Laulicht M, Garidi M, Economidou J, Georgipoulou P, Hussain MA, Flynn DM.
    Lancet; 1979 May 05; 1(8123):947-9. PubMed ID: 87616
    [Abstract] [Full Text] [Related]

  • 10. Treatment of iron overload in adults with continuous parenteral desferrioxamine.
    Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC.
    Am J Med; 1977 Dec 05; 63(6):958-66. PubMed ID: 605917
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Deferoxamine in hemosiderosis. Fecal iron excretion during continuous subcutaneous infusion].
    Krüger N, Kijewski H, König R, Tillmann W, Schröter W.
    Dtsch Med Wochenschr; 1984 Nov 02; 109(44):1682-5. PubMed ID: 6489181
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E, Bianco I, Graziani B, Lerone M, Valente M, Congedo P, Ponzini D, Costantini S.
    Acta Haematol; 1982 Nov 02; 68(2):115-23. PubMed ID: 6812366
    [Abstract] [Full Text] [Related]

  • 15. [Continuous subcutaneous desferrioxamine infusions in patients with hemosiderosis (author's transl)].
    Tillmann W, König R, Schröder K, Schröter W.
    Monatsschr Kinderheilkd; 1982 Mar 02; 130(3):171-2. PubMed ID: 7087975
    [No Abstract] [Full Text] [Related]

  • 16. Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia associated with the 5q-syndrome.
    Ambruso DR, Mahony BS, Githens JH, Rhoades ED.
    Am J Pediatr Hematol Oncol; 1982 Mar 02; 4(2):115-23. PubMed ID: 7114394
    [Abstract] [Full Text] [Related]

  • 17. Iron metabolism in thalassemia intermedia.
    Fiorelli G, Fargion S, Piperno A, Battafarano N, Cappellini MD.
    Haematologica; 1990 Mar 02; 75 Suppl 5():89-95. PubMed ID: 2086386
    [Abstract] [Full Text] [Related]

  • 18. [Current status of treatments with desferrioxamine B in post-transfusion hypersiderosis in children].
    Orsini A, Raybaud C, Bernard PJ, Aquaron R, Passeron P.
    Mars Med; 1967 Mar 02; 104(4):331-7. PubMed ID: 5621537
    [No Abstract] [Full Text] [Related]

  • 19. Early iron overload in beta-thalassaemia major: when to start chelation therapy?
    Fargion S, Taddei MT, Gabutti V, Piga A, Di Palma A, Capra L, Fontanelli G, Avanzini A.
    Arch Dis Child; 1982 Dec 02; 57(12):929-33. PubMed ID: 7181522
    [Abstract] [Full Text] [Related]

  • 20. Continuous high-dose intravenous desferrioxamine treatment for iron overload.
    Sidi Y, Shaklai M, Liban E, Pinkhas J.
    Isr J Med Sci; 1981 May 02; 17(5):348-51. PubMed ID: 7263191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.